Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Blankenstein

Showing results (91-100 of 138) with videos related to

Pageof 14
Sort By:
Cancer Research|October 10, 2014
Efficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγAna Textor, Joanna J Listopad, Lara Le Wührmann, et al.
Cancer Letters|April 30, 2008
Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient miceDmitry V Kuprash, Zhihai Qin, Daisuke Ito, et al.
Elife|April 20, 2021
In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivoGerald Willimsky, Christin Beier, Lena Immisch, et al.
European Journal of Immunology|August 7, 2010
Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivoShabnam Shalapour, Katrin Deiser, Ozen Sercan, et al.
Zentralblatt Fur Chirurgie|September 18, 2025
[The Free Functional Latissimus dorsi Flap for the Reconstruction of Complex Abdominal Wall Defects: Anatomy, Technique and Approach for Interdisciplinary Treatment]Sinan Mert, Benedikt Fuchs, Alexander Burges, et al.
Cancer Research|June 11, 2013
Vaccine-instructed intratumoral IFN-γ enables regression of autochthonous mouse prostate cancer in allogeneic T-cell transplantationRodrigo Hess Michelini, Teresa Manzo, Tabea Sturmheit, et al.
Frontiers in Immunology|January 8, 2025
Generation of effective and specific human TCRs against tumor/testis antigen NY-ESO-1 in mice with humanized T cell recognition systemXiaojing Tina Chen, Matthias Leisegang, Ioannis Gavvovidis, et al.
Oncogene|January 30, 2003
Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic miceKarin Lange, Wolfgang Uckert, Thomas Blankenstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLsBernhard Frankenberger, Heike Pohla, Elfriede Noessner, et al.
Nature Biotechnology|March 17, 2015
Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized miceMatthias Obenaus, Catarina Leitão, Matthias Leisegang, et al.
Pageof 14

Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
Cancer Research|October 10, 2014
Efficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγAna Textor, Joanna J Listopad, Lara Le Wührmann, et al.
Cancer Letters|April 30, 2008
Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient miceDmitry V Kuprash, Zhihai Qin, Daisuke Ito, et al.
Elife|April 20, 2021
In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivoGerald Willimsky, Christin Beier, Lena Immisch, et al.
European Journal of Immunology|August 7, 2010
Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivoShabnam Shalapour, Katrin Deiser, Ozen Sercan, et al.
Zentralblatt Fur Chirurgie|September 18, 2025
[The Free Functional Latissimus dorsi Flap for the Reconstruction of Complex Abdominal Wall Defects: Anatomy, Technique and Approach for Interdisciplinary Treatment]Sinan Mert, Benedikt Fuchs, Alexander Burges, et al.
Cancer Research|June 11, 2013
Vaccine-instructed intratumoral IFN-γ enables regression of autochthonous mouse prostate cancer in allogeneic T-cell transplantationRodrigo Hess Michelini, Teresa Manzo, Tabea Sturmheit, et al.
Frontiers in Immunology|January 8, 2025
Generation of effective and specific human TCRs against tumor/testis antigen NY-ESO-1 in mice with humanized T cell recognition systemXiaojing Tina Chen, Matthias Leisegang, Ioannis Gavvovidis, et al.
Oncogene|January 30, 2003
Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic miceKarin Lange, Wolfgang Uckert, Thomas Blankenstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLsBernhard Frankenberger, Heike Pohla, Elfriede Noessner, et al.
Nature Biotechnology|March 17, 2015
Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized miceMatthias Obenaus, Catarina Leitão, Matthias Leisegang, et al.
Pageof 14